Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives $51.25 Average Target Price from Analysts
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) has been assigned an average rating of “Buy” from the seven analysts that are currently covering the stock, Marketbeat Ratings reports. Six analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1 year target […]
More Stories
White House’s Muddled Responses Added Fuel to the Fire in Alex Pretti’s Shooting in Minneapolis
Chaos spread around the White House like wildfire in the tense hours after Border Patrol agents fatally shot Alex Pretti,...
Top 12 Video Editing Tools That are Worth Using for US YouTubers
Think about this, you are a YouTuber, and you have uploaded a video, and in hours your video is going...
November US Trade Deficit Widens 94 Percent After Reaching 16-Year Low
By Andrew Moran The U.S. trade deficit in goods and services widened by the most since 1992, one month after...
AG Paxton Announces Investigation Into H-1B Visa Abuse
By Naveen Athrappully Texas Attorney General Ken Paxton is probing the abuse of the H-1B visa program in the state,...
Trump Shares Video Showing Earlier Violent Confrontation Between Pretti and Federal Agents
By Tom Ozimek President Donald Trump on Jan. 28 shared newly released video footage showing Alex Pretti in a violent...
Who is Angela Marmol? Height, Age, and News with Tom Cruise
A social media influencer, Angela, rose to fame through social media platforms like TikTok and Instagram. She is known for...